RRLThis looks unfinished, i suspect its in wave 3 of [C], so a bit more downside to end wave 3 then a bounce in wave 4 followed by wave 5 of [C].$2.30 looks a target of interest.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%